Louisiana State Employees Retirement System acquired a new position in shares of Ingevity Corporation (NYSE:NGVT – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,900 shares of the company’s stock, valued at approximately $1,133,000.
A number of other hedge funds have also modified their holdings of the company. Global Retirement Partners LLC acquired a new stake in Ingevity in the 4th quarter valued at approximately $27,000. Meeder Asset Management Inc. acquired a new position in Ingevity during the 4th quarter worth approximately $33,000. Kestra Advisory Services LLC bought a new position in shares of Ingevity during the 4th quarter worth approximately $47,000. Geneos Wealth Management Inc. grew its stake in shares of Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new stake in shares of Ingevity in the second quarter valued at approximately $46,000. 91.59% of the stock is currently owned by institutional investors.
Ingevity Stock Down 0.3%
NGVT stock opened at $72.28 on Friday. The company has a market cap of $2.51 billion, a price-to-earnings ratio of -20.36 and a beta of 1.16. Ingevity Corporation has a twelve month low of $39.74 and a twelve month high of $79.29. The business has a 50 day moving average price of $71.23 and a two-hundred day moving average price of $69.10. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83.
Wall Street Analyst Weigh In
NGVT has been the topic of a number of research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 29th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $80.00.
Get Our Latest Stock Analysis on Ingevity
Insider Transactions at Ingevity
In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.88% of the company’s stock.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Articles
- Five stocks we like better than Ingevity
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil JalapeƱo: An Early Step to Massive AI Growth Potential
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
